“Evaluation of human placental-based cellular, acellular and matrix-like products (CAMPs) in the management of nonhealing diabetic foot ulcers: an interim analysis of the CAMPSTIM clinical trial”, ijtr, vol. 1, no. Suppl 2, Oct. 2025, doi: 10.63676/mp9mtt23.